Olopatadine formulations for topical administration
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 7, 2006
Grant Date -
Mar 20, 2003
app pub date -
Jun 19, 2002
filing date -
Jun 27, 2001
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Topical formulations of olopatadine for treatment of allergic or inflammatory disorders of the eye and nose are disclosed. The aqueous formulations contain approximately 0.17-0.62% (w/v) of olopatadine and an amount of polyvinylpyrrolidone or polystyrene sulfonic acid sufficient to enhance the physical stability of the formulations.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully